Paul Tudor Jones Agios Pharmaceuticals, Inc. Transaction History

Tudor Investment Corp Et Al

$26.8 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$21.32 - $34.81 $167,063 - $272,771	7,836 Added 28.09%	35,734 $1.04 Million
Q4 2023 Feb 14, 2024	BUY	$19.97 - $24.53 $557,123 - $684,337	27,898 New	27,898 $621,000
Q1 2023 May 15, 2023	SELL	$21.74 - $30.93 $235,009 - $334,353	-10,810 Reduced 42.28%	14,755 $339,000
Q4 2022 Feb 14, 2023	BUY	$24.81 - $31.52 $79,913 - $101,525	3,221 Added 14.42%	25,565 $718,000
Q3 2022 Nov 14, 2022	SELL	$19.51 - $34.14 $7,491 - $13,109	-384 Reduced 1.69%	22,344 $632,000
Q2 2022 Aug 15, 2022	SELL	$17.06 - $31.42 $965,715 - $1.78 Million	-56,607 Reduced 71.35%	22,728 $504,000
Q1 2022 May 16, 2022	SELL	$26.68 - $34.81 $119,526 - $155,948	-4,480 Reduced 5.35%	79,335 $2.31 Million
Q4 2021 Feb 14, 2022	BUY	$29.58 - $49.78 $2.48 Million - $4.17 Million	83,815 New	83,815 $2.76 Million
Q2 2021 Aug 16, 2021	SELL	$52.06 - $61.27 $400,341 - $471,166	-7,690 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$44.23 - $57.5 $764,161 - $993,427	-17,277 Reduced 69.2%	7,690 $397,000
Q4 2020 Feb 16, 2021	SELL	$33.21 - $46.54 $1.04 Million - $1.46 Million	-31,371 Reduced 55.68%	24,967 $1.08 Million
Q3 2020 Nov 16, 2020	BUY	$33.87 - $55.93 $1.34 Million - $2.21 Million	39,493 Added 234.45%	56,338 $1.97 Million
Q2 2020 Aug 14, 2020	BUY	$34.45 - $53.48 $580,310 - $900,870	16,845 New	16,845 $901,000
Q4 2019 Feb 14, 2020	SELL	$30.08 - $50.59 $415,555 - $698,900	-13,815 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$32.4 - $49.58 $150,789 - $230,745	4,654 Added 50.8%	13,815 $448,000
Q2 2019 Aug 14, 2019	BUY	$46.17 - $68.1 $422,963 - $623,864	9,161 New	9,161 $457,000

Others Institutions Holding AGIO

# of Institutions

232

Shares Held

58.1M

Call Options Held

403K

Put Options Held

469K

Farallon Capital Management LLC San Francisco, CA

5.66M
Shares

$195 Million
1.26% of portfolio
Vanguard Group Inc Valley Forge, PA

5.55M
Shares

$191 Million
0.0% of portfolio
Black Rock Inc. New York, NY

4.86M
Shares

$167 Million
0.0% of portfolio
Bellevue Group Ag Kuesnacht, V8

3.74M
Shares

$129 Million
2.8% of portfolio
Price T Rowe Associates Inc Baltimore, MD

2.83M
Shares

$97.5 Million
0.01% of portfolio

View Full List

About AGIOS PHARMACEUTICALS, INC.

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $1.89B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

More about AGIO

Track Paul Tudor Jones's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Account